Royal Bank of Canada’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $253M | Buy |
|
|||||
|
2025
Q1 | $143M | Sell |
|
|||||
|
2024
Q4 | $169M | Buy |
|
|||||
|
2024
Q3 | $130M | Sell |
|
|||||
|
2024
Q2 | $228M | Sell |
|
|||||
|
2024
Q1 | $260M | Buy |
|
|||||
|
2023
Q4 | $203M | Sell |
|
|||||
|
2023
Q3 | $277M | Sell |
|
|||||
|
2023
Q2 | $443M | Buy |
|
|||||
|
2023
Q1 | $370M | Sell |
|
|||||
|
2022
Q4 | $359M | Sell |
|
|||||
|
2022
Q3 | $401M | Sell |
|
|||||
|
2022
Q2 | $503M | Sell |
|
|||||
|
2022
Q1 | $721M | Sell |
|
|||||
|
2021
Q4 | $842M | Sell |
|
|||||
|
2021
Q3 | $738M | Sell |
|
|||||
|
2021
Q2 | $676M | Buy |
|
|||||
|
2021
Q1 | $508M | Sell |
|
|||||
|
2020
Q4 | $554M | Buy |
|
|||||
|
2020
Q3 | $482M | Buy |
|
|||||
|
2020
Q2 | $360M | Buy |
|
|||||
|
2020
Q1 | $313M | Buy |
|
|||||
|
2019
Q4 | $345M | Sell |
|
|||||
|
2019
Q3 | $357M | Sell |
|
|||||
|
2019
Q2 | $305M | Buy |
|
|||||
|
2019
Q1 | $295M | Buy |
|
|||||
|
2018
Q4 | $224M | Sell |
|
|||||
|
2018
Q3 | $269M | Buy |
|
|||||
|
2018
Q2 | $219M | Sell |
|
|||||
|
2018
Q1 | $216M | Buy |
|
|||||
|
2017
Q4 | $160M | Buy |
|
|||||
|
2017
Q3 | $145M | Buy |
|
|||||
|
2017
Q2 | $156M | Buy |
|
|||||
|
2017
Q1 | $123M | Buy |
|
|||||
|
2016
Q4 | $110M | Buy |
|
|||||
|
2016
Q3 | $138M | Buy |
|
|||||
|
2016
Q2 | $114M | Sell |
|
|||||
|
2016
Q1 | $104M | Buy |
|
|||||
|
2015
Q4 | $89.1M | Buy |
|
|||||
|
2015
Q3 | $30.8M | Buy |
|
|||||
|
2015
Q2 | $20.9M | Buy |
|
|||||
|
2015
Q1 | $19.9M | Sell |
|
|||||
|
2014
Q4 | $20.3M | Buy |
|
|||||
|
2014
Q3 | $11.5M | Buy |
|
|||||
|
2014
Q2 | $6.16M | Sell |
|
|||||
|
2014
Q1 | $5.56M | Sell |
|
|||||
|
2013
Q4 | $6.6M | Buy |
|
|||||
|
2013
Q3 | $6.46M | Sell |
|
|||||
|
2013
Q2 | $7.15M | Buy |
|